1481 related articles for article (PubMed ID: 25704036)
1. BAY 11-7082 ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated oxidative stress and renal inflammation via NF-κB pathway.
Kolati SR; Kasala ER; Bodduluru LN; Mahareddy JR; Uppulapu SK; Gogoi R; Barua CC; Lahkar M
Environ Toxicol Pharmacol; 2015 Mar; 39(2):690-9. PubMed ID: 25704036
[TBL] [Abstract][Full Text] [Related]
2. Suppression of NF-κB and NF-κB regulated oxidative stress and neuroinflammation by BAY 11-7082 (IκB phosphorylation inhibitor) in experimental diabetic neuropathy.
Kumar A; Negi G; Sharma SS
Biochimie; 2012 May; 94(5):1158-65. PubMed ID: 22342224
[TBL] [Abstract][Full Text] [Related]
3. Andrographolide ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated renal oxidative stress and inflammation via Akt/NF-κB pathway.
Ji X; Li C; Ou Y; Li N; Yuan K; Yang G; Chen X; Yang Z; Liu B; Cheung WW; Wang L; Huang R; Lan T
Mol Cell Endocrinol; 2016 Dec; 437():268-279. PubMed ID: 27378149
[TBL] [Abstract][Full Text] [Related]
4. Danshen injection ameliorates STZ-induced diabetic nephropathy in association with suppression of oxidative stress, pro-inflammatory factors and fibrosis.
Xu L; Shen P; Bi Y; Chen J; Xiao Z; Zhang X; Wang Z
Int Immunopharmacol; 2016 Sep; 38():385-94. PubMed ID: 27355131
[TBL] [Abstract][Full Text] [Related]
5. Ellagic acid, an NF-κB inhibitor, ameliorates renal function in experimental diabetic nephropathy.
Ahad A; Ganai AA; Mujeeb M; Siddiqui WA
Chem Biol Interact; 2014 Aug; 219():64-75. PubMed ID: 24877639
[TBL] [Abstract][Full Text] [Related]
6. Apigenin ameliorates streptozotocin-induced diabetic nephropathy in rats via MAPK-NF-κB-TNF-α and TGF-β1-MAPK-fibronectin pathways.
Malik S; Suchal K; Khan SI; Bhatia J; Kishore K; Dinda AK; Arya DS
Am J Physiol Renal Physiol; 2017 Aug; 313(2):F414-F422. PubMed ID: 28566504
[TBL] [Abstract][Full Text] [Related]
7. Effects of N-adamantyl-4-methylthiazol-2-amine on hyperglycemia, hyperlipidemia and oxidative stress in streptozotocin-induced diabetic rats.
Yang SJ; Je Lee W; Kim EA; Dal Nam K; Hahn HG; Young Choi S; Cho SW
Eur J Pharmacol; 2014 Aug; 736():26-34. PubMed ID: 24797782
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of diabetic nephropathy by tocotrienol: involvement of NFkB signaling pathway.
Kuhad A; Chopra K
Life Sci; 2009 Feb; 84(9-10):296-301. PubMed ID: 19162042
[TBL] [Abstract][Full Text] [Related]
9. Geniposide reduces development of streptozotocin-induced diabetic nephropathy via regulating nuclear factor-kappa B signaling pathways.
Hu X; Zhang X; Jin G; Shi Z; Sun W; Chen F
Fundam Clin Pharmacol; 2017 Feb; 31(1):54-63. PubMed ID: 27521287
[TBL] [Abstract][Full Text] [Related]
10. Hemin therapy improves kidney function in male streptozotocin-induced diabetic rats: role of the heme oxygenase/atrial natriuretic peptide/adiponectin axis.
Ndisang JF; Jadhav A
Endocrinology; 2014 Jan; 155(1):215-29. PubMed ID: 24140713
[TBL] [Abstract][Full Text] [Related]
11. Taurine ameliorates alloxan-induced diabetic renal injury, oxidative stress-related signaling pathways and apoptosis in rats.
Das J; Sil PC
Amino Acids; 2012 Oct; 43(4):1509-23. PubMed ID: 22302365
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy with spironolactone and candesartan protects against streptozotocin-induced diabetic nephropathy in rats.
Hofni A; El-Moselhy MA; Taye A; Khalifa MM
Eur J Pharmacol; 2014 Dec; 744():173-82. PubMed ID: 25446917
[TBL] [Abstract][Full Text] [Related]
13. Renoprotective effect of Hypericum perforatum against diabetic nephropathy in rats: Insights in the underlying mechanisms.
Abd El Motteleb DM; Abd El Aleem DI
Clin Exp Pharmacol Physiol; 2017 Apr; 44(4):509-521. PubMed ID: 28079268
[TBL] [Abstract][Full Text] [Related]
14. Ferulsinaic acid attenuation of diabetic nephropathy.
Sayed AA
Eur J Clin Invest; 2013 Jan; 43(1):56-63. PubMed ID: 23190272
[TBL] [Abstract][Full Text] [Related]
15. Diltiazem attenuates oxidative stress in diabetic rats.
Anjaneyulu M; Chopra K
Ren Fail; 2005; 27(3):335-44. PubMed ID: 15957552
[TBL] [Abstract][Full Text] [Related]
16. Crocin mediated amelioration of oxidative burden and inflammatory cascade suppresses diabetic nephropathy progression in diabetic rats.
Abou-Hany HO; Atef H; Said E; Elkashef HA; Salem HA
Chem Biol Interact; 2018 Mar; 284():90-100. PubMed ID: 29409856
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol protects diabetic kidney by attenuating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2-Keap1 signaling.
Palsamy P; Subramanian S
Biochim Biophys Acta; 2011 Jul; 1812(7):719-31. PubMed ID: 21439372
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of diabetic nephropathy by Chaihuang-Yishen granule through anti-inflammatory mechanism in streptozotocin-induced rat model of diabetics.
Zhang H; Zhao T; Gong Y; Dong X; Zhang W; Sun S; Wang H; Gu Y; Lu X; Yan M; Li P
J Ethnopharmacol; 2014; 151(1):556-64. PubMed ID: 24269779
[TBL] [Abstract][Full Text] [Related]
19. Metformin attenuates streptozotocin-induced diabetic nephropathy in rats through modulation of oxidative stress genes expression.
Alhaider AA; Korashy HM; Sayed-Ahmed MM; Mobark M; Kfoury H; Mansour MA
Chem Biol Interact; 2011 Jul; 192(3):233-42. PubMed ID: 21457706
[TBL] [Abstract][Full Text] [Related]
20. Effect of irbesartan on the antioxidant defence system and nitric oxide release in diabetic rat kidney.
Anjaneyulu M; Chopra K
Am J Nephrol; 2004; 24(5):488-96. PubMed ID: 15353911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
